Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta …

K Katsanos, S Spiliopoulos, P Kitrou, M Krokidis… - Journal of Vascular and …, 2020 - Elsevier
A formal systematic review and study-level meta-analysis of randomized controlled trials
investigating treatment of the infrapopliteal arteries with paclitaxel-coated balloons …

A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra …

AW Bradbury, CA Moakes, M Popplewell, L Meecham… - The Lancet, 2023 - thelancet.com
Background Chronic limb-threatening ischaemia is the severest manifestation of peripheral
arterial disease and presents with ischaemic pain at rest or tissue loss (ulceration …

Autologous stem cell therapy in critical limb ischemia: a meta‐analysis of randomized controlled trials

B Xie, H Luo, Y Zhang, Q Wang, C Zhou… - Stem Cells …, 2018 - Wiley Online Library
Objective. Critical limb ischemia (CLI) is the most dangerous stage of peripheral artery
disease (PAD). Many basic researches and clinical treatment had been focused on stem cell …

[HTML][HTML] Overcoming ischemia in the diabetic foot: Minimally invasive treatment options

S Spiliopoulos, G Festas… - World Journal of …, 2021 - ncbi.nlm.nih.gov
As the global burden of diabetes is rapidly increasing, the incidence of diabetic foot ulcers is
continuously increasing as the mean age of the world population increases and the obesity …

Efficacy and safety of tibial cortex transverse transport for diabetic foot: A protocol for systematic review and meta-analysis

J Guo, H Bao, Lideer, X Ni, Y Zhao, G Sun - PloS One, 2022 - journals.plos.org
Introduction Diabetic foot (DF) is one of the most serious chronic complications of diabetes.
In recent years, the use of the tibial cortex transverse transport (TTT) technique has enabled …

CIRSE standards of practice on below-the-knee revascularisation

S Spiliopoulos, C Del Giudice, M Manzi… - CardioVascular and …, 2021 - Springer
Abstract The CIRSE Standards of Practice Committee established a writing group that was
tasked with producing up-to-date recommendations for performing below-the-knee …

Safety and efficacy of placenta-derived mesenchymal stem cell treatment for diabetic patients with critical limb ischemia: a pilot study

J Wang, XX Zeng, W Cai, ZB Han… - Experimental and …, 2021 - thieme-connect.com
Aim Diabetic foot has become the main cause of non-traumatic amputation. Stem cell
therapy, especially mesenchymal stem cells (MSCs), holds a great promise as a therapy for …

Midterm outcomes after infrapopliteal interventions in patients with critical limb ischemia based on the TASC II classification of below-the-knee arteries

GD Singh, EK Brinza, J Hildebrand… - Journal of …, 2017 - journals.sagepub.com
Purpose: To analyze the relationship between the new TransAtlantic Inter-Society
Consensus (TASC II) infrapopliteal classification and limb outcomes among patients with …

[HTML][HTML] A comparison of clinical outcomes following femoropopliteal bypass or plain balloon angioplasty with selective bare metal stenting in the bypass versus …

L Meecham, G Bate, S Patel, AW Bradbury - European Journal of Vascular …, 2019 - Elsevier
Objective To compare outcomes in patients with chronic limb threatening ischaemia (CLTI)
due to femoropopliteal (FP), with or without infrapopliteal (IP), disease who underwent FP …

Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia

N Kobayashi, K Hirano, M Yamawaki… - Catheterization and …, 2018 - Wiley Online Library
Objectives We clarified characteristics and clinical outcomes of critical limb ischemia (CLI)
patients who underwent repeat endovascular therapy (EVT) for infrapopliteal lesions …